TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 7.88 Delayed Data As of Oct 15 |  0.00 / 0.00%Today’s Change | 7.62 Today|||52-Week Range 35.86 | -74.52% Year-to-Date |
Latest TCRR News | Press Releases
No recent news for TCR2 Therapeutics Inc.
Today’s Trading
| Previous close | 7.88 |
| Today’s open | 8.27 |
| Day’s range | 7.99 - 8.29 |
| Volume | 10,871 |
| Average volume (3 months) | 561,172 |
| Market cap | $309.0M |
Data as of 3:59pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | +48.09% |
| Earnings growth (this year) | -6.62% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OCXOncoCyte Corp | 0.00 | 0.00% |
| CTXRCitius Pharmaceutica... | 0.00 | 0.00% |
| FBIOFortress Biotech Inc | 0.00 | 0.00% |
| VRNAVerona Pharma PLC | 0.00 | 0.00% |
Data as of 4:25pm ET, 10/15/2021
Financials
| Next reporting date | November 17, 2021 |
| EPS forecast (this quarter) | -$0.64 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$67.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
